Esophageal Adenocarcinoma Methods and Protocols

(sharon) #1

194


4 Notes



  1. Plasma samples from multiple collection tubes can be pooled
    for increased DNA yields.

  2. In order to prevent contamination by leukocytes or other
    DNA containing cells, it may be useful to leave a small layer of
    untouched plasma behind at the plasma/cell interface.
    Pipetting should be performed slowly to avoid disturbing the
    cell layer and operators may consider drawing up the first ~75%
    of available plasma first before attempting the last ~25%.

  3. Use of liquid nitrogen freezing and longer centrifugation in
    the final steps will lead to increased DNA yield, but also higher
    proportions of contaminants. Adjust accordingly.


References



  1. Gallerani G, Fabbri F (2016) Circulating tumor
    cells in the adenocarcinoma of the esophagus.
    Int J Mol Sci 17:1266

  2. Boldrin E, Rumiato E, Fassan M, Balsamo L,
    Realdon S, Battaglia G, Rugge M, Amadori A,
    Saggioro D (2016) Liquid biopsy as a novel
    tool to monitor the carcinogenesis of Barrett's
    esophagus. Transl Res 2176:127–131

  3. Feller SM, Lewitzky M (2016) Hunting for the
    ultimate liquid cancer biopsy – let the TEP
    dance begin. Cell Commun Signal 14:24

  4. Alix-Panabières C, Pantel K (2013) Circulating
    tumor cells: liquid biopsy of cancer. Clin Chem
    59:110–118

  5. Brock G, Castellanos-Rizaldos E, Hu L,
    Coticchia C, Skog J (2015) Liquid biopsy for
    cancer screening, patient stratification and
    monitoring. Transl Cancer Res 4:280–290

  6. Sclafani F, Smyth E, Cunningham D, Chau I,
    Turner A, Watkins D (2014) A pilot study
    assessing the incidence and clinical significance
    of circulating tumor cells in esophagogastric
    cancers. Clin Colorectal Cancer 13:94–99

  7. Zhang J, Bowers J, Liu L, Wei S, Gowda GA,
    Hammoud Z, Raftery D (2015) Esophageal
    cancer metabolite biomarkers detected by
    LC-MS and NMR methods. PLoS One
    7:e30181

  8. Schmidt H, Kulasinghe A, Kenny L, Punyadeera
    C (2016) The development of a liquid biopsy


for head and neck cancers. Oral Oncol
61:8–11


  1. Kisiel JB, Konijeti GG, Piscitello AJ, Chandra
    T, Goss TF, Ahlquist DA, Farraye FA,
    Ananthakrishnan AN (2016) Stool DNA analy-
    sis is cost-effective for colorectal cancer surveil-
    lance in patients with ulcerative colitis. Clin
    Gastroenterol Hepatol 14:1778–1787

  2. Kaczor-Urbanowicz KE, Martin Carreras-
    Presas C, Aro K, Tu M, Garcia-Godoy F, Wong
    DT (2017) Saliva diagnostics – current views
    and directions. Exp Biol Med 242:459–472

  3. Pan W, Gu W, Nagpal S, Gephart MH, Quake
    SR (2015) Brain tumor mutations detected in
    cerebral spinal fluid. Clin Chem 61:514–522

  4. Ignatiadis M, Lee M, Jeffrey SS (2015)
    Circulating tumor cells and circulating tumor
    DNA: challenges and opportunities on the
    path to clinical utility. Clin Cancer Res
    21:4786–4800

  5. Muller L, Hong CS, Stolz DB, Watkins SC,
    Whiteside TL (2014) Isolation of biologically-
    active exosomes from human plasma.
    J Immunol Methods 411:55–65

  6. Kim JW, Wieckowski E, Taylor DD, Reichert
    TE, Watkins S, Whiteside TL (2005) Fas
    ligand-positive membranous vesicles isolated
    from sera of patients with oral cancer induce
    apoptosis of activated T lymphocytes. Clin
    Cancer Res 11:1010–1020


Robert A. Smith and Alfred K. Lam
Free download pdf